StonvexLoading…
StonvexStonvexStonvexCore line items from RDNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.04B | $1.83B | $1.62B | $1.43B |
Operating Income | $61.99M | $104.62M | $98.70M | $46.36M |
Net Income | $-18.65M | $2.79M | $3.04M | $10.65M |
EPS (Diluted) | $-0.25 | $0.04 | $0.05 | $0.17 |
Total Assets | $3.76B | $3.29B | $2.69B | $2.43B |
Total Liabilities | $2.40B | $2.15B | $1.88B | $1.94B |
Cash & Equivalents | $767.22M | $740.02M | $342.57M | $127.83M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 74.04M | 74.04M | 67.96M | 57.72M |